COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 1548: Articles 15471-15480  | Next

Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Fogh, K., Eriksen, A. R., Hasselbalch, R. B., Kristensen, E. S., Bundgaard, H., Nielsen, S. D., Joergensen, C. S., Scharff, B. F., Erikstrup, C., Saekmose, S. G., Holm, D. K., Aagaard, B., Norsk, J. B., Nielsen, P. B., Kristensen, J. H., Oestergaard, L., Ellermann-Eriksen, S., Andersen, B., Nielsen, H., Johansen, I. S., Wiese, L., Simonsen, L., Fischer, T. R., Folke, F., Lippert, F., Ostrowski, S. R., Ethelberg, S., Koch, A., Vangsted, A.-M., Krause, T. G., Formsgaard, A., Nielsen, C., Ullum, H., Skov, R., Iversen, K.
10.1101/2021.05.07.21256725 — Posted: 2021-05-10
Saudi Arabian SARS-CoV-2 genomes implicate a mutant Nucleocapsid protein in modulating host interactions and increased viral load in COVID-19 patients
Mourier, T., Shuaib, M., Hala, S., Mfarrej, S., Alofi, F., Naeem, R., Alsomali, A., Jorgensen, D., Subudhi, A. K., Ben Rached, F., Guan, Q., Salunke, R., Ooi, A., Esau, L., Douvropoulou, O., Nugmanova, R., Perumal, S., Zhang, H., Rajan, I., Al-Omari, A., Salih, S., Shamsan, A., Al Mutair, A., Taha, J., Alahmadi, A., Khotani, N., Alhamss, A., Mahmoud, A., Alquthami, K., Dageeg, A., Khogeer, A., Hashem, A. M., Moraga, P., Volz, E., Almontashiri, N., Pain, A.
10.1101/2021.05.06.21256706 — Posted: 2021-05-10
A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality
FILLATRE, P., DUFOUR, M. J., BEHILLIL, S., VATAN, R., REUSSE, P., GABELLEC, A., VELMANS, N., MONTAGNE, C., GEFFROY, S., DROUMAGUET, E., MEROUR, V., Enouf, V., BUZELE, R., VALENCE, M., GUILLOTEL, E., GAGNIERE, B., BAIDALUK, A., ZHUKOVA, A., TOURDJMAN, M., THIBAULT, V., GROLHIER, C., PRONIER, C., LESCURE, X., SIMON-LORIERE, E., COSTAGLIOLA, D., VAN DER WERF, S., TATTEVIN, P., MASSART, N.
10.1101/2021.05.05.21256690 — Posted: 2021-05-10
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
Miyakawa, K., Jeremiah, S. S., Kato, H., Yamaoka, Y., Go, H., Yamanaka, T., Ryo, A.
10.1101/2021.05.06.21256788 — Posted: 2021-05-10
Estimated Spike Evolution and Impact of Emerging SARS-CoV-2 Variants
Lu, Y., Han, K., Xue, G., Zheng, N., Jin, G.
10.1101/2021.05.06.21256705 — Posted: 2021-05-10
INDIA'S PRAGMATIC VACCINATION STRATEGY AGAINST COVID-19: A MATHEMATICAL MODELLING BASED ANALYSIS
Mandal, S., Arinaminpathy, N., Bhargava, B., Panda, S.
10.1101/2021.05.07.21256742 — Posted: 2021-05-10
COVID-19 Compromises In The Medical Practice And The Consequential Effect On Endometriosis Patients
Ashkenazi, S., Huseby, O. L., Kroken, G., Soto, L. A., Pents, M., Tran, G., Lewandowska, R., Lo Schivo, A., kwiatkowski, S.
10.1101/2021.05.04.21255000 — Posted: 2021-05-10
Yet another lockdown? A large-scale study on people's unwillingness to be confined during the first 5 months of the COVID-19 pandemic in Spain
Martinez-Garcia, M., Rabasa, A., Barber, X., Polotskaya, K., Roomp, K., Oliver, N.
10.1101/2021.05.08.21256792 — Posted: 2021-05-10
Effect of using personal protective equipment during the COVID-19 pandemic on the quality indicators of screening colonoscopies.
Chirayath, S. G., Bahirwani, J., Kaur, P., Martins, N., Modi, R.
10.1101/2021.05.07.21256743 — Posted: 2021-05-10
Social and racial/ethnic differences in parental willingness to vaccinate children against COVID-19 in Montreal, Canada
McKinnon, B., Quach Thanh, C., Dube, E., Tuong Nguyen, C., Zinszer, K.
10.1101/2021.05.08.21256831 — Posted: 2021-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).